Through
1/1
PHILADELPHIA — Patients with uveitis, the fifth leading cause of vision loss in the United States, treated with either systemic anti-inflammatory medicine or with a time-release implant surgically placed inside the eye experienced a similar degree of visual improvement over two years, according to a new study from researchers at the Perelman School o
PHILADELPHIA — A $10 million grant from the National Cancer Institute will fund a new center at the Perelman School of Medicine at the University of Pennsylvania focusing on the relationship between exercise, weight loss, and improving the length and quality of life for the nation's 12 million cancer survivors.
PHILADELPHIA — A pandemic of ailments called the "allergic march" -- the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood -- has frustrated both parents and physicians.
PHILADELPHIA — A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania
(PHILADELPHIA) -- In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineer
PHILADELPHIA — Flax has been part of human history for well over 30,000 years, used for weaving cloth, feeding people and animals, and even making paint.
Philadelphia — In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development.
Philadelphia — In a recent issue of Cancer Research, Daniel J.
PHILADELPHIA -- Ezekiel J. Emanuel, a globally renowned bioethicist, will join the faculty of the University of Pennsylvania as the 13th Penn Integrates Knowledge University Professor, beginning Sept. 1. The announcement was made by Penn President Amy Gutmann and Provost Vincent Price.
Philadelphia — The Institute for Translational Medicine and Therapeutics (ITMAT) of the Perelman School of Medicine at the University of Pennsylvania received a $55 million renewal from the NIH in recognition for their success during the first five years of the Clinical and Translational Science Awards (CTSA) program.
Scott Hensley of the Perelman School of Medicine says the latest H5N1 bird flu strain might have a greater potential to adapt and cause severe disease in humans.
FULL STORY →
Colleen Tewksbury of the School of Nursing and Perelman School of Medicine says that the vast majority of people in the U.S. already get enough protein from the foods they eat and don’t need to take it in supplement form.
FULL STORY →
Postdoc Amritha Mallikarjun of the School of Veterinary Medicine says that dogs use buttons as a trained behavior to try and get the things they want.
FULL STORY →
Scientists at Penn are trying to develop a template for groups of rare conditions that are similar enough to be affected by a single, easily adaptable gene-editing treatment.
FULL STORY →
Samir Mehta of the Perelman School of Medicine says that older adults playing sports need to understand who their competition is and make sure they’re playing with people who are at the appropriate level.
FULL STORY →